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Adeno-associated virus type 2 (AAV2) provokes a DNA damage response that mimics a stalled replication
fork. We have previously shown that this response is dependent on ataxia telangiectasia-mutated and Rad3-
related kinase and involves recruitment of DNA repair proteins into foci associated with AAV2 DNA. Here, we
investigated whether recombinant AAV2 (rAAV2) vectors are able to produce a similar response. Surprisingly,
the results show that both single-stranded and double-stranded green fluorescent protein-expressing rAAV2
vectors are defective in producing such a response. We show that the DNA damage signaling initiated by AAV2
was not due to the virus-encoded Rep or viral capsid proteins. UV-inactivated AAV2 induced a response similar
to that of untreated AAV2. This type of DNA damage response was not provoked by other DNA molecules, such
as single-stranded bacteriophage M13 or plasmid DNAs. Rather, the results indicate that the ability of AAV2
to produce a DNA damage response can be attributed to the presence of cis-acting AAV2 DNA sequences, which
are absent in rAAV2 vectors and could function as origins of replication creating stalled replication complexes.
This hypothesis was tested by using a single-stranded rAAV2 vector containing the p5 AAV2 sequence that has
previously been shown to enhance AAV2 replication. This vector was indeed able to trigger DNA damage
signaling. These findings support the conclusion that efficient formation of AAV2 replication complexes is
required for this AAV2-induced DNA damage response and provide an explanation for the poor response in
rAAV2-infected cells.
Adeno-associated virus (AAV) is a replication-defective sin-
gle-stranded DNA virus of the Parvoviridae family. Productive
infection of AAV requires the presence of a helper virus, such
as adenovirus (Ad) or herpes virus (1, 2, 38, 41). AAV has a
genome size of 4.7 kb and encodes two types of protein: the
Rep polypeptides involved in its replication and the capsid
proteins used for its encapsidation (16). The AAV genes are
flanked by inverted terminal repeats (ITRs), which form a
characteristic hairpin structure (13, 17). Infections by viruses
are frequently followed by a host cell response that may either
protect the host against the viral invasion or, alternatively, help
the viral life cycle (21). In the case of AAV, a DNA damage
response is provoked in the host cell, which potentially could
be explained as a reaction to the single-stranded DNA part of
the virus. It has been reported that transfection of cells with a
random oligonucleotide can cause a p53-dependent apoptotic
response (29). Alternatively, the hairpin structures of AAV
DNA could be responsible for this type of response (6).
It has previously been shown by ourselves and others that
treatment of AAV2 with UV light (UV-AAV2) inactivates the
Rep and Cap genes and that subsequent infection in the ab-
sence of helper virus leads to a significant DNA damage re-
sponse and to perturbation of the cell cycle (19, 33, 42). This
involves an arrest of the cell cycle at G2 and an increase of the
levels of the p53 and p21 proteins (33). This DNA damage
signaling pathway has been further examined and has been
shown to resemble the response provoked by chemically in-
duced stalled DNA replication forks. It is demonstrated by the
formation of foci, which include AAV2 DNA localized with
proteins involved in replication, such as replication protein A
(RPA) and DNA polymerase  (19). RPA has also been found
to be associated with AAV2 replication fork progression (8, 27,
36). The AAV2-induced DNA damage response is also fol-
lowed by activation of ataxia telangiectasia-mutated (ATM)
and Rad3-related (ATR) proteins, leading to phosphorylation
of Chk1 (19). Other indicators of this type of DNA damage
response include phosphorylated H2AX (-H2AX) and hyper-
phosphorylated RPA32 (11, 12, 34, 44). In the case of p53-
deficient cells, infection with UV-AAV2 leads to cell death
(33). This phenomenon has been attributed to mitotic catas-
trophe as a result of proteosome-dependent degradation of
Chk1 (18). The wild-type (WT) AAV2 virions can also activate
a DNA damage response pathway that is dependent on Rep
proteins and involves a cell cycle arrest at S phase (3).
AAV2 is widely used in gene therapy research due to its low
immunogenicity, integration ability, and the absence of patho-
genicity (4, 10, 15, 20). Despite these advantages, recombinant
AAV2 (rAAV2) vectors are unable to integrate site specifically
(24, 26, 32). Moreover, they give low levels of transgene ex-
pression, at least partly due to the inability of the recombinant
virus to replicate efficiently. Tullis and Shenk (37) showed that
DNA sequences in the AAV2 early region can act in cis to
enhance viral replication, and these have been narrowed down
to an element within the p5 promoter of AAV2 (14, 37). Gene
expression from rAAV2 vectors was enhanced when Ad or
genotoxic stress was applied, and this was attributed to the fact
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that under these conditions double-stranded AAV2 DNA
could be more easily produced from the single-stranded viral
genome. Indeed, the double-stranded (self-complementary)
rAAV2 vectors have higher transduction efficiencies, as they
bypass the second-strand synthesis step required for AAV2
replication (23, 24). Both single- and double-stranded rAAV
vectors have DNA hairpin structures that are recognized as
recombination intermediates and therefore attract proteins
that are involved in double-strand break repair, such as Mre11
and ATM (7). Nevertheless, whether rAAV2 vectors can cause
a DNA damage response as exhibited by cell cycle arrest and
formation of DNA repair foci is not known.
In this study we investigated whether the single-stranded or
the double-stranded (self-complementary) rAAV2 vectors
could produce a DNA damage response similar to the one
observed with the WT AAV2 or UV-AAV2. Because rAAV2
vectors are used in gene therapy research as well as in clinical
trials, it is important to know the reaction of the infected cells
to the virus. Both types of vector DNA contain hairpin struc-
tures, which could potentially lead to a DNA damage response.
Furthermore, the single-stranded rAAV2 vector could lead to
DNA damage signaling through its single-stranded DNA struc-
ture. However, our results show that neither of the two rAAV2
vectors is capable of inducing a significant DNA damage re-
sponse. We attribute this deficiency to the reduced ability
of rAAV2 vectors to replicate and therefore to the absence of
AAV2-stalled replication forks. Indeed, a single-stranded
rAAV2 vector containing the p5 region of AAV2 that has been
shown to function in the initiation of viral DNA replication was
able to induce a DNA damage response.
MATERIALS AND METHODS
Cell lines, chemicals, and nucleic acids. All experiments were performed using
U2OS osteosarcoma cells, which were grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum (FBS), penicillin/strepto-
mycin, and ciprofloxacin (Ciproxin; Bayer). HeLa cells were used for the pro-
duction of virus and were maintained in the same medium. Doxorubicin, DAPI
(4,6,diamidino-2-phenylindole), and RNase A were obtained from Sigma.
Doxorubicin was used at a final concentration of 50 nM. Proteinase K
(Boeringer) was used at a final concentration of 100 g/ml. M13 DNA was
obtained from Fermentas (M13mp18). The plasmid used in the study was ob-
tained from Promega (pRL-TK). The 36-Cy3 oligonucleotide (AAG-TGT-TAC-
CGA-TAG-ACC-AGA-CCT-GAG-CTA-TGG-GAG) was designed randomly
using the Vector-NTI program. The 55-Cy3 oligonucleotide (CTG-GGT-ATT-
TAA-GCC-CGA-GTG-AGC-ACG-CAG-GGT-CTC-CAT-TTT-GAA-GCG-
GGA-GGT-T) contains the AAV2 nucleotides 250 to 304.
Virus stocks, vectors, and infections. AAV2 was used for all experiments.
Virus was produced following the protocol described by Q. Xie et al. (43).
Briefly, HeLa cells were transfected with a linearized AAV2 plasmid, followed by
infection with Ad type 5 (Ad5). When a full cytopathic effect was observed, the
cell lysate was harvested and used to perform a secondary infection of HeLa
cells. At 2 to 3 days after the secondary infection, the cells were lysed, and virus
was pelleted by high-speed centrifugation. The AAV2 particles were finally
obtained after two or three cycles of CsCl gradient centrifugation and stored at
70°C. The single-stranded green fluorescent protein (ssGFP)-AAV2 and dou-
ble-stranded GFP (dsGFP)-AAV2 vectors have been described before (23, 39).
The p5GFP-AAV2 vector was made by substituting the chicken -actin promoter
of ssGFP-AAV2 vector with the AAV2 p5 promoter (AAV2 nucleotides 162 to
324).
AAV2 samples were heat treated at 60°C for 45 min to inactivate any remain-
ing Ad (the effectiveness of this treatment was verified) and then used to infect
cells in a small quantity of plain Dulbecco’s modified Eagle’s medium for 3 to 5 h.
Complete medium was then added to the cells, which were analyzed 1 to 4 days
postinfection. AAV2 was used at a multiplicity of infection (MOI) of 10,000,
whereas the dsGFP-AAV2 vector was used at an MOI of 20,000, and the
ssGFP-AAV2 and the p5GFP-AAV2 vectors were used at an MOI of 30,000.
High MOIs were required for efficient transduction by rAAV2 vectors. Ad5
coinfection was performed after AAV2 infection overnight in normal medium at
an MOI of 3.
UV radiation and proteinase K treatments. UV treatment of AAV2 was
performed to inactivate the virus. In brief, virus samples were diluted in 50 l of
phosphate-buffered saline (PBS) and then treated with UV light using a UV
Stratalinker 2400 (Stratagene) at 240 mJ/cm2. M13 and plasmid DNAs were
treated with UV light in the same way.
For the proteinase K treatment AAV2 was diluted in Tris-EDTA buffer
containing 0.05% NP-40, 0.05% Tween, and 100 g/ml of proteinase K. The
sample was incubated at 68°C for 1 h and then at 95°C for another 1 h to
inactivate the enzyme.
Transfections. Transfections were performed using Lipofectamine 2000 re-
agent (Invitrogen) according to the manufacturer’s instructions.
Immunofluorescence staining. Cells were plated 1 day before infection onto
fibronectin-treated coverslips and analyzed 1 to 4 days postinfection. They were
washed twice with PBS and then fixed with formaldehyde (5%) for 10 min. The
cells were then washed three times with PBS and incubated in blocking buffer
(0.5% NP-40, 5% milk powder, 1% FBS) for 30 min. After being washed once
with PBS, cells were incubated in buffer containing 5% milk powder, 1% FBS,
and primary antibodies for 45 to 60 min. Coverslips were washed with PBS three
times and then incubated with the appropriate secondary antibodies for 45 to 60
min. Cells were washed twice with PBS and then stained with 0.1 g/ml DAPI for
45 s. Finally, they were washed with PBS and distilled water and mounted onto
diazabicyclooctane-glycerol (50%).
The primary antibodies used were the following: anti-phospho-RPA32 S4/S8
(05-636; Bethyl), anti-RPA32 (NA18; Oncogene Research), anti-H2AX Ser139
(JBW301; Upstate Cell Signaling), and anti-Rep (a kind gift from P. Saudan).
The secondary antibodies used were Alexafluor-488, Alexafluor-568 (Molecular
Probes), and Cy3 (Jackson Immunoresearch) immunoglobulin G conjugates.
Images were obtained using a Zeiss Axioplan fluorescence microscope.
Propidium iodide staining and fluorescence-activated cell sorting (FACS)
analysis. Cells were trypsinized, washed with PBS, and then resuspended and
incubated in 70% ethanol at 70°C for 60 min. The samples were washed with
PBS and then resuspended in 0.1 mg/ml RNase A solution. Cells were incubated
at 37°C for 15 to 20 min and then mixed with an equal volume of 20 g/ml of
propidium iodide. The samples were finally analyzed using a flow cytometer
(Beckton-Dickinson).
Western blotting. Cells were collected, washed with PBS, and resuspended in
2.5 volumes of reporter lysis buffer (Promega) supplemented with a cocktail of
protease inhibitors (Calbiochem). Samples were incubated on ice for 30 min and
then centrifuged at 16,000  g for 20 min at 4°C. Protein concentrations were
measured using the Bradford method (Bio-Rad), and 40 g of total protein from
each sample was resolved on a 10% sodium dodecyl sulfate-polyacrylamide gel.
The protein samples were then transferred (semidry transfer) onto a nitrocellu-
lose membrane (Bio-Rad), which was then blocked overnight in blocking solu-
tion (5% milk powder–0.1% Tween in PBS). The membrane was incubated with
primary antibodies for 1 h, washed three times with PBS–0.1% Tween, incubated
with secondary antibodies for 1 h, and finally washed three times with PBS–0.1%
Tween. The blots were visualized using an ECL assay (Amersham) following the
manufacturer’s instructions. The primary antibodies used were the following:
anti-MCM3 (minichromosome maintenance 3 complex) (ab4460; Abcam), anti-
Rep, and anti-AAV2 viral protein (VP) (61058; Progen). Horseradish peroxi-
dase-conjugated immunoglobulin G antibodies (Jackson Immunoresearch) were
used as secondary antibodies.
RESULTS
rAAV2 vectors do not provoke a DNA damage response
typical of a stalled replication fork. In order to investigate
whether the rAAV2 vectors can lead to DNA damage signal-
ing, we compared a single-stranded AAV2 vector expressing
the GFP gene under the control of a chicken -actin promoter
(ssGFP-AAV2) and a double-stranded AAV vector expressing
the GFP gene under the control of a cytomegalovirus promoter
(dsGFP-AAV2) to WT AAV2 (Fig. 1A). Both rAAV2 vectors
contain the 145-bp AAV2 ITR sequence at both ends. We
initially infected U2OS osteosarcoma cells with either WT
AAV2 or UV-AAV2 (UV-treated AAV2 to inactivate Rep
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and Cap genes). Infected cells were fixed and immunostained
1 day postinfection for phosphorylated RPA32 (Fig. 1B). Both
WT AAV2 and UV-AAV2 infections resulted in phosphory-
lation and accumulation of RPA32 into foci, indicating that a
DNA damage response was activated that was due to the
AAV2 DNA and not its protein products (Fig. 1B). DNA
damage signaling was also examined by staining the cells for
the phosphorylated version of histone variant H2AX (-
H2AX) 4 days after infection (Fig. 1C). Phosphorylation of
H2AX is a widely used indicator of different types of response
to DNA damage (12). Based on -H2AX staining, WT AAV2
caused a significant DNA damage response, similar to that
provoked by UV-AAV2. Moreover, both WT AAV2 and UV-
AAV2 caused cell cycle checkpoint activation and a subse-
quent G2 arrest, as can be concluded from the inhibited growth
and the increased nuclear size of the infected cells 4 days
postinfection (Fig. 1C) and FACS analysis (Fig. 2).
FIG. 1. AAV2 infection induces a DNA damage response. (A) De-
scription of the viruses used in this study. (B) U2OS cells infected with
WT AAV2 or UV-AAV2 and stained with phospho-RPA32 antibody
at 1 day postinfection. Cell nuclei were stained with DAPI. (C) In-
fected cells were stained with -H2AX antibody 4 days postinfection. FIG. 2. rAAV2 vectors do not induce a significant DNA damage
response. (A) U2OS cells infected with UV-AAV2, ssGFP-AAV2, or
dsGFP-AAV2 and examined 1 day postinfection by staining with
RPA32 antibody. Cell nuclei were stained with DAPI. GFP was used
to identify the infected cells. (B) Infected cells were also examined 4
days postinfection by staining with -H2AX antibody. (C) U2OS cells
infected with either WT AAV2 or rAAV2 vectors, stained with pro-
pidium iodide, and analyzed by FACS 1 day postinfection. UV-AAV2-
infected and doxorubicin-treated cells served as controls.
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We then infected U2OS cells with either the ssGFP-AAV2
or the dsGFP-AAV2 vectors and used UV-AAV2-infected
U2OS cells as a control. Infected cells were examined 1 day
postinfection for GFP expression and DNA repair focus for-
mation by staining with an antibody against RPA32 (Fig. 2A).
Infected cells expressing GFP did not form foci, suggesting that
the rAAV2 particles did not induce a DNA damage response.
Cells were also examined 4 days postinfection by staining with
anti--H2AX antibody and identifying GFP-expressing cells
(Fig. 2B). Both ssGFP-AAV2 and dsGFP-AAV2 vectors failed
to produce significant H2AX phosphorylation, indicating again
that the rAAV2 vectors were incapable of initiating DNA
damage signaling. The absence of this signaling can also be
deduced from the fact that the nuclei of the cells infected with
the recombinant viruses did not enlarge, in contrast to the
nuclei of the UV-AAV2-infected cells (Fig. 2B).
The host cell response to rAAV2 vectors was also assayed by
propidium iodide staining and FACS analysis (Fig. 2C). U2OS
cells were infected with the rAAV2 vectors, WT AAV2, and
UV-AAV2 and analyzed 1 day postinfection. Doxorubicin
treatment was also used as a control, as it is known to produce
a significant G2 cell cycle arrest. As shown in Fig. 2C, rAAV2
vectors were deficient in arresting the infected cells in G2,
whereas the WT AAV2 and UV-AAV2 were capable of pro-
ducing a significant G2 cell cycle arrest.
The DNA damage response is independent of Rep. In order
to investigate further the source of the DNA damage response
provoked by UV-AAV2, we examined whether treatment of
the virus with UV light inactivated the viral genes. We infected
U2OS cells with WT AAV2 or UV-AAV2 with or without Ad5
coinfection and then stained the cells 1 day postinfection for
Rep proteins and for H2AX to identify infected cells (Fig.
3A). Cells infected with WT AAV2, both in the presence or
absence of helper virus, expressed the Rep gene. On the other
hand, UV-AAV2-infected cells, as well as Ad5-infected and
noninfected cells, did not express Rep in any case (Fig. 3A).
This indicates that the DNA damage signaling observed in
U2OS cells after infection with UV-AAV2 cannot be attrib-
uted to Rep proteins.
Rep expression was also examined by Western blotting.
U2OS cells were infected with WT AAV2 or UV-AAV2, with
or without the presence of Ad5 helper virus, and protein was
extracted 1 day after infection. Protein samples were separated
on a sodium dodecyl sulfate-polyacrylamide gel and blotted
against Rep antibody (Fig. 3B). This experiment again shows
that no detectable Rep is expressed from the UV-AAV2. Un-
infected U2OS cells or cells infected with Ad5 did not express
any Rep either (Fig. 3B). Taken together, these data indicate
that AAV2 DNA itself can cause a significant DNA damage
response, independently of Rep.
The DNA damage response is independent of the viral cap-
sid. The next step in our study was to investigate whether the
AAV2 capsid has a role in the induced DNA damage response.
The role of the capsid in this kind of response was assayed by
treating WT virus with proteinase K to destroy the capsid
polypeptides. The proteinase K-treated AAV2 virions were
further treated with UV light to inactivate any potential gene
expression. The UV-AAV2 DNA was then used to transfect
U2OS cells by lipofection, and transfected cells were finally
immunostained for -H2AX and phospho-RPA32 1 day post-
transfection. As shown in Fig. 4A, the viral capsid is dispens-
able for the production of the DNA damage response, and the
AAV2 genome alone is sufficient to induce this response.
U2OS cells treated with Lipofectamine did not show any signs
of DNA damage signaling (Fig. 4A).
In order to assay the effectiveness of the proteinase K treat-
ment on the AAV2 capsid proteins, U2OS cells were infected
with AAV2 or AAV2 treated with proteinase K and then
coinfected with Ad5. Total protein was extracted 3 days postin-
fection and used for Western blotting against AAV2 capsid
proteins (VP polypeptides). Cells infected with proteinase K-
treated AAV2, as well as Ad5-infected and noninfected cells,
did not show any signs of AAV2 capsid proteins (Fig. 4B). On
FIG. 3. Rep is not responsible for the UV-AAV2-induced DNA
damage response. (A) Immunofluorescence experiment showing that
UV-AAV2-infected U2OS cells initiate a DNA damage response (-
H2AX staining) without expressing Rep. Cells were infected with
AAV2 either treated or not with UV light in the presence or absence
of Ad5 and stained 1 day postinfection. Cells infected with Ad5 only
were used as controls. (B) Western blot showing that UV-AAV2-
infected U2OS cells do not express Rep 1 day after infection. MCM3
served as a loading control. NI, noninfected; WT, wild-type AAV2;
UV, UV-AAV2.
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the other hand, the cells infected with AAV2 and Ad5 ex-
pressed AAV2 capsid protein VP3. These data indicate that
the proteinase K treatment was functional and therefore con-
firms the conclusion that the viral capsid is not responsible for
the DNA damage response observed in UV-AAV2-infected
cells.
The DNA damage response is independent of the UV treat-
ment per se. We then examined whether the UV treatment per
se could be responsible for the DNA damage response ob-
served in UV-AAV2-infected cells. UV treatment of the virus
can create protein-DNA links that could potentially provoke
such a response. rAAV2 vectors as well as WT AAV2 were
treated with UV light and then used to infect U2OS cells. Cells
were stained with propidium iodide 1 day postinfection and
then analyzed by FACS (Fig. 5A). The UV-treated rAAV2
vectors were unable to initiate a DNA damage signaling path-
way, as assayed by cell cycle analysis.
The DNA damage response in the cells infected with the
FIG. 4. AAV2 capsid is not responsible for the UV-AAV2-induced DNA damage response. (A) U2OS cells transfected with proteinase
K-treated UV-AAV2 particles and immunostained for both -H2AX and phospho-RPA32 1 day posttransfection. Cell nuclei were stained with
DAPI. Lipofectamine-treated cells served as controls. (B) Control Western blotting to show that proteinase K treatment of AAV2 was functional.
Presence of AAV2 particles was assayed in AAV2- or proteinase K-treated AAV2-infected (Ad5 coinfected) U2OS cells by staining for AAV2
capsid protein VP3 (61 kDa). The Ad5-infected U2OS sample served as a control. NI, noninfected.
FIG. 5. UV treatment is not responsible for the UV-AAV2-induced DNA damage response. (A) U2OS cells infected with UV-treated rAAV2
vectors, stained with propidium iodide, and analyzed by FACS do not arrest at G2. UV-AAV2-infected cells served as a control. (B) Infected cells
were stained with -H2AX antibody 4 days postinfection to show the absence of a DNA damage response from the UV-treated rAAV2 vectors.
Cell nuclei were stained with DAPI. (C) U2OS cells infected with UV-treated rAAV2 vectors and stained for phospho-RPA32. Cells infected with
UV-AAV2 were used as a control for phospho-RPA32 staining. Cells infected with the dsGFP-AAV2 vector were used as a control for GFP
staining.
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UV-treated rAAV2 vectors was in addition assayed by immu-
nostaining cells for -H2AX 4 days after infection (Fig. 5B).
UV-AAV2 caused massive phosphorylation of H2AX, whereas
UV-treated rAAV2 vectors did not produce significant H2AX
phosphorylation. Furthermore, rAAV2 vectors were unable to
cause a G2 arrest, as can be concluded from the density and
size of the nuclei, in contrast to UV-AAV2-infected cells (Fig.
5B). The cells were also examined for AAV2-induced DNA
repair foci by phospho-RPA32 staining 1 day postinfection
(Fig. 5C). Again, the UV-treated rAAV2 vectors did not in-
duce formation of DNA repair foci. Cells were also tested for
GFP production to confirm that the UV treatment was suffi-
cient to inactivate gene expression from the virus samples.
Altogether, these data indicate that the UV treatment itself
cannot account for the significant DNA damage signaling that
is observed in U2OS cells infected with UV-AAV2 and that
this type of response is probably AAV2 DNA specific.
The DNA damage response is specific to AAV2 DNA. We
next addressed the question of whether the observed DNA
damage response is specific to the AAV2 DNA sequence. For
this reason U2OS cells were transfected with either bacterio-
phage M13 or plasmid DNA, both of which were treated with
UV light prior to transfection to inactivate any potential gene
expression. M13 DNA is a 7.3-kb single strand, whereas the
plasmid used was a double-stranded 4-kb DNA plasmid (see
Materials and Methods). Cells were immunostained for
H2AX and phospho-RPA32 1 day posttransfection (Fig. 6A).
Neither the M13 nor the plasmid DNA could initiate a DNA
damage response comparable to the one produced by UV-
AAV2. This indicates that the response observed in U2OS
cells after infection with UV-AAV2 is specific to an AAV2
DNA sequence and cannot be produced by any DNA frag-
ment.
To validate this finding, we transfected U2OS cells with a
randomly designed oligonucleotide (36-mer–Cy3). The oligo-
nucleotide used was Cy3-tagged so as to identify the trans-
fected cells. Transfected cells were examined 1 day posttrans-
fection by immunofluorescence analysis for the DNA damage
indicators H2AX and phospho-RPA32. As shown in Fig. 6B
this random piece of single-stranded DNA was not capable of
initiating a DNA damage response, confirming the conclusion
that the DNA damage signaling cascade cannot be initiated by
any kind of DNA fragment.
The next step in our study was to investigate whether a
single-stranded AAV2 DNA sequence itself is able to lead to a
DNA damage response. We have shown that the DNA damage
response induced by UV-AAV2 is similar to the response
provoked by chemically induced stalled replication forks (19).
It has also been demonstrated that the p5 AAV2 sequence acts
in cis to enhance viral replication (37). This sequence has been
suggested to act as an origin of replication for AAV2 and is
considered to be important for AAV2 site-specific integration
(28, 30, 31). This cis-acting replication element (CARE) has
been narrowed down to 55 nucleotides (AAV2 DNA nucleo-
tides 250 to 304) containing the p5 TATA box, the terminal
resolution site, and the Rep binding site (14). We thus de-
signed an oligonucleotide comprised of this 55-nucleotide
AAV2 DNA element tagged with Cy-3 (55-mer–Cy3) and used
it to transfect U2OS cells and test whether this sequence itself
can cause a DNA damage response. We selected this AAV2
sequence to design the oligonucleotide because the p5 se-
quence is the AAV2 part that is present in WT AAV2 and not
in the rAAV2 vectors and could therefore account for the
observed DNA damage response. The samples were assayed 1
FIG. 6. The DNA damage response is specific to AAV2 DNA. (A) Im-
munofluorescence experiment showing that the DNA damage response can-
not be caused by any DNA fragment. U2OS cells were transfected with
UV-treated M13 or plasmid DNA and compared to UV-AAV2-infected
cells. Cells were stained 1 day posttreatment for -H2AX and phospho-
RPA32. Lipofectamine-treated cells were used as a control. (B) U2OS cells
were transfected with two different oligonucleotides conjugated to Cy3 and
then stained with -H2AX and phospho-RPA32 antibodies. UV-AAV2-
infected cells were used as a control. Merged pictures include DAPI staining
of nuclei.
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day posttransfection by staining for immunofluorescence with
phospho-H2AX and phospho-RPA32 antibodies (Fig. 6B).
The results show that the oligonucleotide containing the 55-
nucleotide AAV2 sequence cannot lead to a significant DNA
damage response. This indicates that the AAV2 55-nucleotide
element is not sufficient to cause a DNA damage response and
cannot explain, by itself, the massive response observed in
UV-AAV2-infected U2OS cells.
An rAAV2 vector containing p5 provokes a DNA damage
response. We then constructed a single-stranded rAAV2 vec-
tor expressing GFP under the control of the AAV2 p5 pro-
moter (p5GFP-AAV2), which contains the 55-nucleotide
CARE sequence, and asked the question whether this virus
can provoke a DNA damage response. To answer this ques-
tion, U2OS cells were infected with the p5GFP-AAV2 vector
(UV treated or not) and stained with propidium iodide 1 day
postinfection. Subsequent analysis by FACS shows that the
cells infected with the p5GFP-AAV2 vector arrested at the G2
phase of the cell cycle (Fig. 7A). The effect of the p5GFP-
AAV2 infection on the host cell was also examined by immu-
nostaining infected U2OS cells for the DNA damage response
marker -H2AX 1 day after infection (Fig. 7B). The p5GFP-
AAV2-infected cells showed enhanced staining of -H2AX,
similar to the staining seen in the control UV-AAV2-infected
cells. The p5GFP-AAV2 vector is therefore able to induce a
DNA damage response.
U2OS cells infected with p5GFP-AAV2 were also examined
for AAV2-induced DNA repair focus formation by staining the
cells for proteins known to be found in AAV2-induced stalled
replication forks. Cells were infected and stained for RPA32
and phospho-RPA32 1 day postinfection. As shown in Fig. 7C,
infection with the p5GFP-AAV2 vector led to phospho-
RPA32 staining, although this was not within clear foci, as seen
with WT AAV2. These data altogether show that the rAAV2
vector containing the p5 sequence is capable of inducing the
DNA damage signaling pathway, though without leading to
formation of DNA repair foci. The observed DNA damage
response in UV-AAV2-infected cells can be therefore attrib-
uted in large part to the p5 DNA sequence of AAV2.
DISCUSSION
The data presented here indicate that AAV2 can induce a
significant DNA damage response that is provoked by the
AAV2 DNA sequence itself. The DNA damage signaling path-
way initiated after AAV2 infection cannot be attributed to the
capsid or to single-stranded DNA, as ssGFP-AAV2 virions
include single-stranded DNA enclosed inside a protein capsid
FIG. 7. The rAAV2 vector containing the p5 sequence of AAV2 provokes a DNA damage response. (A) FACS analysis of U2OS cells infected
with p5GFP-AAV2 (UV treated or not) indicating an AAV2-provoked cell cycle arrest. (B) Immunofluorescence staining of p5GFP-AAV2-
infected cells with phospho-H2AX antibody. DAPI staining was used to stain the nuclei, and GFP was used to indicate the infected cells.
UV-AAV2-infected cells were used as a control for -H2AX staining. (C) Cells stained with RPA32 and phospho-RPA32 antibodies to identify
AAV2-induced DNA repair foci. UV-AAV2-infected cells were used as a positive control for such foci.
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yet do not induce a detectable DNA damage response. More-
over, a long fragment of single-stranded DNA from phage M13
as well as a double-stranded circular DNA was unable to in-
duce DNA damage signaling. The DNA damage response also
cannot be attributed to the ITR hairpin structures of AAV2
DNA as they exist in the genome of the rAAV2 vectors that do
not lead to DNA damage signaling. Nor can the damage sig-
naling be attributed to Rep, since UV-AAV2 gives an undi-
minished DNA damage response while being unable to pro-
duce detectable Rep. Most importantly, the new vector we
generated that contains the AAV2 p5 region (p5GFP-AAV2)
triggers damage signaling but encodes no Rep polypeptides.
This experiment thus excludes the possibility that the response
is due to Rep. The effect of UV-AAV2 on the host cell was also
shown not to be due to the UV treatment itself, as UV-treated
rAAV2 vectors without p5 did not have a significant effect on
the infected cells. Altogether these data indicate that AAV2
contains a sequence, other than its ITRs, that is responsible for
the induction of a DNA damage signaling pathway.
Tullis and Shenk (37) noted that rAAV2 vectors often rep-
licate poorly and identified an AAV2 element in the left part of
the genome that is essential for efficient AAV2 replication.
Nony et al. (28) and Franc¸ois et al. (14) have recently located
this element to a 55-nucleotide sequence within the p5 AAV2
promoter (AAV2 nucleotides 250 to 304), named CARE.
Apart from enhancing replication, this element has also been
shown to have a role in AAV2 integration (30). Given that the
AAV2-induced DNA damage response is biochemically simi-
lar to the response caused by stalled replication forks, we
hypothesized that this element might function as an origin of
replication, creating stalled replication forks and thereby in-
ducing the DNA damage response. To test this hypothesis, we
initially designed a 55-nucleotide-long oligonucleotide com-
prised of the CARE sequence tagged with Cy3. This sequence
by itself could not induce a DNA damage response. This could
be because the CARE fragment alone may not be sufficient to
create a stalled replication fork and thereby initiate a DNA
damage response. This notion would agree with a study show-
ing that M13 single-stranded DNA was able to lead to check-
point activation only when it was primed (22). Activation of the
replication checkpoint by aphidicolin was also shown to re-
quire RNA primer synthesis (25). Therefore, the CARE se-
quence might be able to provoke a DNA damage response only
in the context of AAV2, which could provide the primer re-
quired for the production of stalled replication forks.
To test whether an AAV2-derived virus containing the
CARE fragment would lead to a DNA damage response, a
single-stranded rAAV2 vector was constructed containing the
AAV2 p5 sequence driving the expression of a GFP transgene.
The p5-containing rAAV2 vector was indeed able to lead to
DNA damage signaling. Specifically, p5GFP-AAV2 was able
to arrest cells at the G2 phase of the cell cycle, as well as to lead
to H2AX phosphorylation. This vector triggered staining of the
infected cells by phospho-RPA32 antibody but not the forma-
tion of clear AAV2 DNA repair foci. This could mean that the
AAV2-induced foci represent incomplete AAV2 replication
centers that cannot be formed by p5GFP-AAV2, possibly due
to the requirement for another AAV2 sequence that is not
present in the p5GFP-AAV2 vector. Alternatively, the DNA
damage signaling pathway induced by this rAAV2 vector might
be incomplete and not involve formation of DNA repair foci,
which could be a downstream step of the DNA damage sig-
naling pathway. The ability of the p5GFP-AAV2 vector to
induce a DNA damage response without producing foci is an
interesting observation that deserves further study.
The effect of the p5 region of AAV2 on the DNA damage
response exhibited by AAV-infected cells can be explained by
the presence of a potential origin of replication within this
sequence. The p5 AAV2 promoter contains the CARE se-
quence that has been thought to function as a replication origin
(14, 28). RPA, which has been shown to colocalize with AAV2
replication centers, might recognize and bind to this potential
origin of replication (8, 36, 40). Binding of RPA may then lead
on to formation of a stalled replication fork, because of either
defective AAV2 replication in the absence of helper virus or
UV-induced lesions if the virus is UV inactivated. As a conse-
quence, ATR protein becomes activated, and proteins such as
RPA32 and H2AX become phosphorylated, leading to check-
point activation and cell cycle arrest (Fig. 8). Therefore, initi-
ation of replication at an adequate level is required for a DNA
damage response to be produced. The rAAV2 vectors that do
not contain the p5 sequence are unable to achieve this and are
therefore unable to induce such a DNA damage signaling
pathway.
AAV2 seems able to interact with cellular DNA damage
signaling in several ways. An association of the MRN (Mre11/
Rad50/Nbs1) complex with AAV2 DNA has recently been
reported (5, 35), and such binding acts to limit viral replication
and transduction. Choi et al. (6) have also examined the role of
cellular DNA recombination and repair pathways in AAV2
genome processing and found that, in this case, cellular DNA
repair proteins including Mre11 and Nbs1 are required for
efficient circularization of self-complementary recombinant
AAV2 genomes. The MRN complex is a sensor of double-
strand breaks and is part of the ATM signaling pathway (9).
We have shown previously that the DNA damage response we
observed in AAV2-infected cells, involving cell cycle arrest and
H2AX phosphorylation, is independent of the ATM pathway
(19). We therefore propose that the AAV2 hairpins of either
the WT AAV2 or the rAAV2 vectors may attract the MRN
complex, but the induced DNA damage response in that case
is not as strong as the one seen when stalled DNA replication
FIG. 8. Schematic representation of a model explaining how AAV2
provokes a DNA damage response. Pol, DNA polymerase .
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forks are formed. The DNA damage signaling pathway in-
duced by p5 promoter-containing AAV2, which includes acti-
vation of ATR and Chk1 proteins, is possibly so strong and
dominant that under these conditions it does not allow any
other signaling pathway to be easily detected.
Summarizing the above results, we have shown that the p5
sequence of AAV2 is required for the production of a DNA
damage response in the AAV2-infected cells. rAAV vectors
that do not include this sequence are unable to provoke DNA
damage signaling, whereas the vector containing this sequence
can initiate a DNA damage response. The data therefore sug-
gest that rAAV2 gene therapy vectors not containing the p5
AAV2 promoter sequence are less likely to affect adversely the
host cells by induction of cellular DNA damage signaling.
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